glp 1 medication oral FDA approves Foundayo, an GLP-1 alternative to Wegovy and Ozempic New oral GLP-1 drugs could

Animal studies -- primarily in rats -- have shown BPC-157 may accelerate healing of tendons, ligaments, muscles, and bones

Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice

Additionally, there is the potential to modify the underlying disease with IL-23 inhibitors

[1] Since then, it has become one of the most studied hormones in metabolic medicine and the biological basis for some of the most talked-about diabetes and weight-loss drugs in the world, like Ozempic

If you have a client thats taking GLP-1s, whats something you want them to look out for